Saks Samuel R Insider Trades

Insider Trading History

Track insider trading activity for Saks Samuel R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Medical Officer
Holding Value $9.25M 90,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 90,000 shares
$23.57
$102.79
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Medical Officer
Holding Value $8.74M 85,000 shares
Last Trade
Feb 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$663k 85,000 shares
$7.80
$102.79
PDL Biopharma
PDL Biopharma PDLI
Holding Value $311k 126,050 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378k 126,050 shares
$3.00
$2.47
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Medical Officer
Holding Value $4.63M 45,000 shares
Last Trade
May 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$486k 45,000 shares
$10.80
$102.79
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Development Officer
Holding Value $1.54M 15,000 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 15,000 shares
$8.02
$102.79
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $238k 20,000 shares
Last Trade
Jun 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.44T 20,000 shares
$272,000,000.00
$11.88
PDL Biopharma
PDL Biopharma PDLI
Holding Value $529k 214,190 shares
Last Trade
Jun 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 54,348 shares
$2.76
$2.47
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Development Officer
Holding Value $5.14M 50,000 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 50,000 shares
$7.28
$102.79
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Development Officer
Holding Value $0 0 shares
Last Trade
May 21, 2018 Sale
$38k 6,000 shares
$6.34
$102.79
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $238k 20,000 shares
Last Trade
Jun 20, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.35T 20,000 shares
$267,520,000.00
$11.88
PDL Biopharma
PDL Biopharma PDLI
Holding Value $395k 159,842 shares
Last Trade
Jun 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 60,729 shares
$2.31
$2.47
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $78.5k 6,605 shares
Last Trade
May 27, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214B 750 shares
$285,440,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $69.6k 5,855 shares
Last Trade
Feb 09, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$276B 750 shares
$367,999,999.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $755k 63,550 shares
Last Trade
Jun 21, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$32.8T 25,000 shares
$1,311,999,999.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $606k 51,050 shares
Last Trade
Jun 21, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.4T 12,500 shares
$1,311,999,999.00
$11.88
PDL Biopharma
PDL Biopharma PDLI
Director
Holding Value $245k 99,113 shares
Last Trade
Jun 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 71,023 shares
$3.52
$2.47
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $89.1k 7,500 shares
Last Trade
May 27, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11T 7,500 shares
$1,465,600,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $45.8k 3,855 shares
Last Trade
Feb 25, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06T 600 shares
$1,772,800,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $0 0 shares
Last Trade
Feb 25, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15T 650 shares
$1,772,800,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Director
Holding Value $89.1k 7,500 shares
Last Trade
Feb 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.3T 7,500 shares
$2,438,400,000.00
$11.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up